DRD5 Antikörper (3rd Cytoplasmic Domain)
Kurzübersicht für DRD5 Antikörper (3rd Cytoplasmic Domain) (ABIN1733787)
Target
Alle DRD5 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- 3rd Cytoplasmic Domain
-
Spezifität
- Reacts with human DRD5 / Dopamine Receptor D5
-
Kreuzreaktivität (Details)
- BLAST analysis of the peptide immunogen showed no homology with other human proteins.
-
Aufreinigung
- Antigen affinity purified
-
Immunogen
- Synthetic 16 amino acid peptide from 3rd cytoplasmic domain of human DRD5 / Dopamine Receptor D5. Percent identity with other species by BLAST analysis: Human (100%), Gorilla (100%), Gibbon (100%), Monkey (100%), Dog (100%), Marmoset (94%)...
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
Working dilution: IHC - P (20 μg/mL)
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- PBS, Sodium azide 0.1 %
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C/-80 °C
-
Informationen zur Lagerung
- Long term: -70°C, Short term: +4°C
-
-
- DRD5 (Dopamine Receptor D5 (DRD5))
-
Andere Bezeichnung
- DRD5 / Dopamine Receptor D5
-
UniProt
- P21918
-
Pathways
- Regulation of Systemic Arterial Blood Pressure by Hormones, cAMP Metabolic Process, Regulation of long-term Neuronal Synaptic Plasticity
Target
-